Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,499,854
+$184,992 QoQ
Shares Held
25,593
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.74%
of 13F equity value
Holder Rank
#1,417
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DELTA FINANCIAL ADVISORS LLC holds $17,401,793 across 7 Drug Manufacturers - General names. JNJ ranks #1 (37.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
25,593 | $6,499,854 | |
| 2 | AMGN |
Amgen Inc
|
10,233 | $3,705,573 | |
| 3 | ABBV |
AbbVie Inc.
|
9,464 | $2,381,520 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,179 | $2,079,001 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,459 | $1,524,567 | |
| 6 | PFE |
Pfizer Inc
|
25,454 | $612,932 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,736 | $598,346 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,499,854 | 25,593 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $6,314,862 | 25,834 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $5,358,763 | 25,894 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $4,830,005 | 26,049 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $3,949,045 | 25,853 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,264,078 | 25,712 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,724,832 | 25,756 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $4,266,067 | 26,324 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,667,739 | 25,094 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $3,967,721 | 25,082 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,896,713 | 24,861 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $3,955,115 | 25,394 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $4,203,876 | 25,398 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $3,872,985 | 24,987 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $4,511,111 | 25,537 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $4,173,521 | 25,548 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $4,529,167 | 25,515 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $4,515,111 | 25,476 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $4,343,467 | 25,390 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $4,081,912 | 25,275 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $4,170,557 | 25,316 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $4,162,492 | 25,327 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,960,152 | 25,163 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $3,804,777 | 25,556 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $3,647,239 | 25,935 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $3,439,539 | 26,230 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||